Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02198131 · ClinicalTrials.gov registry record · NA
Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia
A NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT02198131: Completed NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer, sponsored by Wake Forest University Health Sciences.
NCT02198131 is a NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02198131, a NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia. Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk, such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens after radiation therapy for laryngeal cancer. Pulsed dye laser may improve post radiation dysphonia.
Primary Outcome
Forced choice comparisons will be utilized in the pre and post treatment stroboscopy comparisons.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE laser therapy
Study Locations (1)
North Carolina
- Comprehensive Cancer Center of Wake Forest University - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2009-10 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02198131 record still lists
NCT02198131 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Oral Complications of Radiation Therapy appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.
NCT02198131 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02198131 about?
NCT02198131 is a clinical study titled "Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia". This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia. Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk, such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens after radiation therapy ...
What is the current status of trial NCT02198131?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2009-10. Estimated completion is 2016-06.
What conditions does trial NCT02198131 study?
This clinical trial studies the following conditions: Oral Complications of Radiation Therapy, Stage I Laryngeal Cancer, Stage II Laryngeal Cancer.
What interventions are being tested in trial NCT02198131?
The interventions under investigation include: questionnaire administration (OTHER), laser therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02198131?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02198131 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02198131's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia